Podcast: The UK's New Biosimilars Licensing Pathway
We Discuss The New MHRA Process And Its Global Significance For Biosimilars
In this podcast discussion, Generics Bulletin editor David Wallace talks to Duncan Emerton, director of Custom Intelligence and Analytics for Informa Pharma Intelligence, about the UK's new licensing procedure for biosimilars.
